A survey of renal impairment pharmacokinetic studies for new oncology drug approvals in the USA from 2010 to early 2015 : a focus on development strategies and future directions
Clusterin inhibition mediates sensitivity to chemotherapy and radiotherapy in human cancer
Prevalence and influence on outcome of HER2/neu, HER3 and NRG1 expression in patients with metastatic colorectal cancer
Deguelin induced differentiation of mutated NPM1 acute myeloid leukemia in vivo and in vitro
3-Bromopyruvate enhances TRAIL-induced apoptosis in human nasopharyngeal carcinoma cells through CHOP-dependent upregulation of TRAIL-R2
Long-term exposure to MST-312 leads to telomerase reverse transcriptase overexpression in MCF-7 breast cancer cells
Antitumor activities of the synthetic retinoid ST1926 in two-dimensional and three-dimensional human breast cancer models
Hypoxia as a target for drug combination therapy of liver cancer
Role of the uridine/cytidine kinase 2 mutation in cellular sensitiveness toward 3′-ethynylcytidine treatment of human cancer cells
Dexrazoxane added to doxorubicin-based adjuvant chemotherapy of breast cancer : a retrospective cohort study with a comparative analysis of toxicity and survival
Feasibility study of adjuvant chemotherapy with modified weekly nab-paclitaxel and carboplatin for completely resected non-small-cell lung cancer : FAST-nab
Report of two cases of acute cardiac adverse events in patients with colorectal carcinoma receiving oral capecitabine
Complete response to anti-PD-1 nivolumab in massive skin metastasis from melanoma : efficacy and tolerability in an elderly patient
Severe complicated neutropenia in two patients with metastatic non-small-cell lung cancer treated with nivolumab
Long-term use of pegylated liposomal doxorubicin to a cumulative dose of 4600 mg/m2 in recurrent ovarian cancer